Aizawa Hospital (Location: Matsumoto City, Nagano Prefecture, Director: Takao Aizawa, hereinafter referred to as "Aizawa Hospital"), a Social Medical Corporation Jisenkai, announces the completion of its trial implementation of the generative AI solution for medical institutions "Ubie Generative AI" provided by Ubie Inc. (Headquarters: Chuo-ku, Tokyo, Co-CEOs: Yoshinori Abe, Kota Kubo, hereinafter referred to as "Ubie") and the commencement of its official adoption across the entire hospital.
In conjunction with this, Aizawa Hospital will introduce the mobile app version (iOS compatible) of "Ubie Generative AI" provided by Ubie. By leveraging voice recognition and text generation functions on business iPhones, an environment will be established where generative AI can be utilized anywhere, regardless of ward or outpatient setting, further accelerating the reduction of cognitive load for medical professionals and the standardization of work quality.
Background of Official Adoption
Aizawa Hospital began the trial implementation of "Ubie Generative AI," the first in the Koshinetsu area, in September 2024 (*). Approximately 80 individuals, including doctors, nurses, and staff from the International Affairs Department supporting foreign patients, participated in testing text generation, summarization, and voice recognition functions. As a result, it was confirmed that the mobile version's voice recognition and text generation functions, utilizing business iPhones, demonstrated high effectiveness in various medical settings. Based on the proven contribution to reducing cognitive load and standardizing work quality across diverse departments, the decision was made to officially adopt "Ubie Generative AI" and its mobile app version throughout the hospital.
The 2026 fiscal year medical fee revision policy indicates further strengthening of evaluation for "Medical DX and Data Utilization." Aizawa Hospital established a DX Promotion Office early on and has strategically advanced ICT utilization, including the introduction of RPA and business smartphones. Partnering with Ubie, which has a track record of implementation in over 130 hospitals nationwide and specialized support capabilities, the hospital aims to achieve both further operational efficiency and improved quality of medical care.
*Aizawa Hospital Commences Trial Implementation of "Ubie Generative AI," the First in the Koshinetsu Area (https://prtimes.jp/main/html/rd/p/000000097.000048083.html)
About the "Ubie Generative AI" Mobile App Version
The mobile app version, which Aizawa Hospital is introducing alongside "Ubie Generative AI," was developed by further evolving the recording tasks using voice recognition, such as in discharge conferences within the admission/discharge support room, where particularly high effectiveness was confirmed through previous demonstration experiments at Aizawa Hospital. The following functions can be utilized from a smartphone:
Voice Recognition Function: Automatically creates medical records and nursing records from voice input.
Image Recognition Function: Reads and analyzes paper documents and images.
Text Generation/Summarization: Supports the creation of various medical documents.
Rich Prompt Templates: Supports a wide range of medical tasks.
This app is compatible with iPhone (iOS) and, in combination with the hospital's closed network environment, realizes a secure operational environment that complies with the security requirements of medical institutions. Seamless integration between the desktop and mobile versions enables the utilization of generative AI in diverse settings such as wards, outpatient clinics, and home medical support.
Introduction Effects and Results
Currently, approximately 30 or more workflows (including voice recognition, summarization, medical document creation, conference recording, etc.) are operational through the utilization of the mobile app.
The following are examples of introduction effects and results:
Discharge Conference Record Creation Time: Reduced from 60 minutes to 10 minutes (utilizing voice input and AI summarization).
Number of Discharge Conferences Held: Increased from 4 cases in the month before introduction to a maximum of 20 cases per month after introduction.
Number of Joint Discharge Guidance Fee Claims: Increased from 2 cases in the month before introduction to a maximum of 14 cases per month after introduction.
Future Outlook
Starting with the official adoption of "Ubie Generative AI," Aizawa Hospital will promote further deepening of in-hospital DX. In the future, the hospital will consider building an "In-Hospital Data Integration Platform" that seamlessly links internal data such as electronic health records with "Ubie Generative AI," further developing generative AI utilization while minimizing data preparation work on the hospital's side. Concurrently, investigations will begin into streamlining DPC coding operations and improving revenue through AI, aiming to establish an AI infrastructure that supports not only operational efficiency but also hospital management improvements. Furthermore, in anticipation of the enhanced medical DX evaluation in the 2026 fiscal year medical fee revision, the hospital will steadily advance the flexible deployment of nursing and clerk staff. The time generated by the power of technology will be reinvested in enhancing patient care and providing more specialized medical services, contributing to the creation of an environment where medical professionals can concentrate on their core work.
Comment from Takao Aizawa, Director of Social Medical Corporation Jisenkai and CEO of Aizawa Hospital
"The introduction of 'Ubie Generative AI' further evolves the 'patient-centered medical care' that Aizawa Hospital has long cherished, through the power of technology. I am confident that AI can reduce the burden on medical professionals and maximize the value of 'warm medical care that only humans can provide.' This initiative is not merely about streamlining operations. By increasing productivity in the medical field and effectively utilizing management resources, the entire hospital will gain resilience to change and the ability to respond flexibly to any difficult situation. This will establish a system capable of providing stable medical care in the future. I expect that the practices at Aizawa Hospital will serve as a catalyst for accelerating digital transformation (DX) in hospitals nationwide."
Comment from Katsuyuki Aizawa, Vice Director of Social Medical Corporation Jisenkai, Head of the Management Strategy Department, and Hospital Director of Aizawa Hospital
"Year by year, with the increasing sophistication and complexity of medical care, the burden on each medical professional is growing, while the chronic labor shortage due to a declining working population is becoming more severe. In such circumstances, it is essential for each medical institution to implement initiatives aimed at improving operational efficiency to maintain the medical provision system. With the introduction of 'Ubie Generative AI,' functional generative AI utilization is possible regardless of location, and it is expected to significantly contribute to improving productivity in the medical field. We will create an environment where staff can concentrate more on their core professional duties, further promote patient-centered medical care, and contribute to the development of regional healthcare."
Comment from Naoki Nishimura, Head of the Management Strategy Department's DX Promotion Office
"In our hospital's DX strategy, the introduction of 'Ubie Generative AI' is a crucial step in accelerating transformation in the medical field. By strategically differentiating the use of AI embedded in electronic health records and 'Ubie Generative AI,' we will create an environment where medical professionals can focus on their primary duties, namely patient interaction and advanced medical decision-making. In particular, the development of a mobile app in collaboration with Ubie Inc. enables agile AI utilization regardless of location and will, I am confident, improve workflows in the medical field. Moving forward, we will continue to gather feedback from the field, pursue concrete results, and contribute to the provision of 'warm medical care' to patients by creating an environment where they can concentrate on essential tasks."
Comment from Yoshinori Abe, Co-CEO and Physician at Ubie Inc.
"With the deployment of the mobile app following the trial implementation at Aizawa Hospital, the utilization of generative AI has expanded from 'in front of the desk' to 'all aspects of the medical field.' I am extremely honored to have been able to collaborate on this new development. This official adoption is a pioneering example demonstrating that generative AI can lead to the strengthening of the entire hospital's medical provision system, not just individual operational efficiency. We will deliver the knowledge built with Aizawa Hospital to medical institutions nationwide and contribute to the establishment of a sustainable medical provision system."
Inquiries
For inquiries regarding "Ubie Generative AI" or to request a detailed explanation of its functions, please contact us via the following site.
"Ubie Generative AI" for Medical Institutions Site
【About "Ubie Medical Navi" for Medical Institutions】
"Ubie Medical Navi" is a service package for medical institutions that supports improvements in hospital management and quality of medical care. It offers services such as "Ubie AI Intake" for streamlining the interview process, the AI platform "Ubie Generative AI" available on multiple modalities and devices, and "Ubie DPC Supporter," which simultaneously supports efficiency and revenue improvement in DPC coding operations using our proprietary AI. "Ubie AI Intake" is an intake service that supports operational efficiency for medical institutions by utilizing smartphones and tablets instead of paper questionnaires. Doctors can significantly reduce administrative work associated with electronic health record entries by utilizing the translated interview content and the results of the disease name dictionary. "Ubie Generative AI" allows the use of multiple AI functions such as text generation, voice recognition, image recognition, and text search (RAG) for various tasks on mobile devices like smartphones and tablets, in addition to electronic health record terminals. As a result, it increases the time spent with patients, allowing them to concentrate more on tasks such as patient care. As of January 2026, "Ubie Generative AI" has been introduced in over 130 hospitals, including university hospitals, and the cumulative number of introductions across hospitals and clinics nationwide reaches over 1,800 in 47 prefectures. It received the "Minister of Health, Labour and Welfare Award" and the "Special Jury Prize" at the 3rd Japan Service Awards, and the "Special Prize" and "Excellence Award" at the "Generative AI Award 2024" in December 2024.
Ubie Medical Navi: https://intro.dr-ubie.com/
Ubie Generative AI: https://intro.dr-ubie.com/hospitals/generativeai_lp
【List of Services Provided by Ubie Inc.】
▽ "Ubie" - AI Medical Partner for Consumers & Symptom Search Engine "Ubie"
Japan Version: https://ubie.app/
US Version: https://ubiehealth.com
▽ "Ubie Medical Navi" for Medical Institutions
https://intro.dr-ubie.com/
▽ "Ubie Generative AI" for Medical Institutions
https://intro.dr-ubie.com/hospitals/generativeai_lp
▽ "Ubie for Pharma" for Pharmaceutical Companies
https://ph-ubie.com/
【About Ubie Inc.】
A health-tech startup founded in May 2017 by a physician and engineers with the mission to "guide people to appropriate medical care through technology." Using AI as its core technology, it develops and provides services such as "Ubie," which guides consumers to appropriate medical care, and "Ubie Medical Navi," a package of services for medical institutions that supports improvements in the quality of medical care. The company is working to create a society where everyone can access the medical care that suits them.
Location: Nihonbashi Life Science Building 4 5F, 3-8-4 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023
Established: May 2017
Representatives: Co-CEO and Physician Yoshinori Abe, Co-CEO Kota Kubo
URL: https://ubie.life
FACT BOX
- Source: PR TIMES
- Category: 企業PR